This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singer, L.
Right arrow Articles by Baley, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singer, L.
Right arrow Articles by Baley, J.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 100 No. 6 December 1997, pp. 987-993

A Longitudinal Study of Developmental Outcome of Infants With Bronchopulmonary Dysplasia and Very Low Birth Weight

Received Nov 26, 1996; accepted Apr 16, 1997.

Lynn Singer*, §, parallel , Toyoko Yamashita*, Dagger , Lawrence Lilien, Marc Collin*, parallel , and Jill Baley*, §

From the Departments of * Pediatrics and Dagger  Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio;§ University Hospitals, Cleveland, Ohio; parallel  MetroHealth Medical Center, Cleveland, Ohio; and  Fairview General Hospital, Cleveland, Ohio.

Objective.  Bronchopulmonary dysplasia (BPD) is now the leading cause of lung disease in US infants. In a large regional cohort, we tested the hypothesis that despite innovations in neonatal care, very low birth weight (VLBW) infants (<1500 g) with BPD had poorer developmental outcomes than nonaffected infants during the first 3 years of life, and that BPD predicted poorer outcome beyond the effects of other risk factors.

Methods.  Three groups of infants (122 with BPD, 84 VLBW without BPD, and 123 full-term) were followed longitudinally to 3 years of age with the Bayley Scales of Mental and Motor Development. Comparison groups of VLBW infants without BPD and full-term infants did not differ in sex, race, or socioeconomic status. Statistical analyses included hierarchical and stepwise multiple regression.

Results.  Infants with BPD performed more poorly at all ages. By 3 years, cognitive and/or motor development was in the range of retardation (<70 standard score) for 21% to 22% of infants with BPD. In multiple regression analyses controlling for socioeconomic and neonatal risk conditions, BPD had an independent negative effect on motor outcome at 3 years. Neurologic risk, a summary measure of neurologic problems other than intraventricular hemorrhage, and the presence of BPD independently predicted motor delay. By 3 years, social class, race, and neurologic risk predicted mental outcome, suggesting that the specific effects of BPD are primarily on the motor domain.

Conclusions.  In VLBW infants, BPD predicts poorer motor outcome at 3 years, after control for other risks. Cohorts of infants with BPD also had higher rates of mental retardation, associated with greater neurologic and social risk. These findings underscore the need for intensive prevention and habilitation efforts for this growing group of VLBW survivors, as well as investigation into the potential role of BPD in the higher rates of learning disabilities in VLBW cohorts at school age.

Key words: bronchopulmonary dysplasia, very low birth weight, infant development, chronic lung disease, surfactant, socioeconomic status.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
M. Laughon, M. T. O'Shea, E. N. Allred, C. Bose, K. Kuban, L. J. Van Marter, R. A. Ehrenkranz, A. Leviton, and for the ELGAN Study Investigators
Chronic Lung Disease and Developmental Delay at 2 Years of Age in Children Born Before 28 Weeks' Gestation
Pediatrics, August 1, 2009; 124(2): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
K. Kobaly, M. Schluchter, N. Minich, H. Friedman, H. G. Taylor, D. Wilson-Costello, and M. Hack
Outcomes of Extremely Low Birth Weight (<1 kg) and Extremely Low Gestational Age (<28 Weeks) Infants With Bronchopulmonary Dysplasia: Effects of Practice Changes in 2000 to 2003
Pediatrics, January 1, 2008; 121(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
E. J. Short, H. L. Kirchner, G. R. Asaad, S. E. Fulton, B. A. Lewis, N. Klein, S. Eisengart, J. Baley, C. Kercsmar, M. O. Min, et al.
Developmental Sequelae in Preterm Infants Having a Diagnosis of Bronchopulmonary Dysplasia: Analysis Using a Severity-Based Classification System
Arch Pediatr Adolesc Med, November 1, 2007; 161(11): 1082 - 1087.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. R. Wilkinson, D. M. Brosi, and Z. D. Jiang
Functional Impairment of the Brainstem in Infants With Bronchopulmonary Dysplasia
Pediatrics, August 1, 2007; 120(2): 362 - 371.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. C. Brown, L. W. Doyle, M. J. Bear, and T. E. Inder
Alterations in Neurobehavior at Term Reflect Differing Perinatal Exposures in Very Preterm Infants
Pediatrics, December 1, 2006; 118(6): 2461 - 2471.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. K. Washburn, P. A. Nixon, and T. M. O'Shea
Follow-up of a Randomized, Placebo-Controlled Trial of Postnatal Dexamethasone: Blood Pressure and Anthropometric Measurements at School Age
Pediatrics, October 1, 2006; 118(4): 1592 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. M Black and A. Baqui
Reply to E Pollitt
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 201 - 202.
[Full Text] [PDF]


Home page
PediatricsHome page
A. R. Laptook, T. M. O' Shea, S. Shankaran, B. Bhaskar, and and the NICHD Neonatal Network
Adverse Neurodevelopmental Outcomes Among Extremely Low Birth Weight Infants With a Normal Head Ultrasound: Prevalence and Antecedents
Pediatrics, March 1, 2005; 115(3): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
N S Wood, K Costeloe, A T Gibson, E M Hennessy, N Marlow, A R Wilkinson, and for the EPICure Study Group
The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F134 - F140.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
K J Collard, S Godeck, J E Holley, and M W Quinn
Pulmonary antioxidant concentrations and oxidative damage in ventilated premature babies
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2004; 89(5): F412 - F416.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. J. Short, N. K. Klein, B. A. Lewis, S. Fulton, S. Eisengart, C. Kercsmar, J. Baley, and L. T. Singer
Cognitive and Academic Consequences of Bronchopulmonary Dysplasia and Very Low Birth Weight: 8-Year-Old Outcomes
Pediatrics, November 1, 2003; 112(5): e359 - 359.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. Schmidt, E. V. Asztalos, R. S. Roberts, C. M. T. Robertson, R. S. Sauve, M. F. Whitfield, and for the Trial of Indomethacin Prophylaxis in Prete
Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results From the Trial of Indomethacin Prophylaxis in Preterms
JAMA, March 5, 2003; 289(9): 1124 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
B Bohm and M Katz-Salamon
Cognitive development at 5.5 years of children with chronic lung disease of prematurity
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F101 - F105.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. T. D'Angio, R. A. Sinkin, T. P. Stevens, N. K. Landfish, J. L. Merzbach, R. M. Ryan, D. L. Phelps, D. R. Palumbo, and G. J. Myers
Longitudinal, 15-Year Follow-up of Children Born at Less Than 29 Weeks' Gestation After Introduction of Surfactant Therapy Into a Region: Neurologic, Cognitive, and Educational Outcomes
Pediatrics, December 1, 2002; 110(6): 1094 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Pediatr. Rev.Home page
Y. E. Vaucher
Bronchopulmonary Dysplasia: An Enduring Challenge
Pediatr. Rev., October 1, 2002; 23(10): 349 - 358.
[Full Text] [PDF]


Home page
PediatricsHome page
J. M. Briet, L. van Sonderen, M. Buimer, K. Boer, and J. H. Kok
Neurodevelopmental Outcome of Children Treated With Antenatal Thyrotropin-Releasing Hormone
Pediatrics, August 1, 2002; 110(2): 249 - 253.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P L Clark, I I Ekekezie, H A Kaftan, C A Castor, and W E Truog
Safety and efficacy of nitric oxide in chronic lung disease
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2002; 86(1): F41 - 45.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. Avent, D. Coile, and L. Mathai
Neonatal Chronic Lung Disease
Journal of Pharmacy Practice, June 1, 2001; 14(3): 181 - 206.
[Abstract] [PDF]


Home page
J Child NeurolHome page
S. R. Snodgrass, V.V. Vedanarayanan, C. C. Parker, and B. R. Parks
Pediatric Patients With Undetectable Anticonvulsant Blood Levels: Comparison With Compliant Patients
J Child Neurol, March 1, 2001; 16(3): 164 - 168.
[Abstract] [PDF]


Home page
J. Nutr.Home page
S. A. Abrams
Chronic Pulmonary Insufficiency in Children and Its Effects on Growth and Development
J. Nutr., March 1, 2001; 131(3): 938S - 941.
[Abstract] [Full Text]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
M Katz-Salamon, E M Gerner, B Jonsson, and H Lagercrantz
Early motor and mental development in very preterm infants with chronic lung disease
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 1F - 6.
[Abstract] [Full Text]


Home page
PediatricsHome page
B. R. Vohr, L. L. Wright, A. M. Dusick, L. Mele, J. Verter, J. J. Steichen, N. P. Simon, D. C. Wilson, S. Broyles, C. R. Bauer, et al.
Neurodevelopmental and Functional Outcomes of Extremely Low Birth Weight Infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994
Pediatrics, June 1, 2000; 105(6): 1216 - 1226.
[Abstract] [Full Text]


Home page
Arch Pediatr Adolesc MedHome page
M. Palta, M. Sadek-Badawi, M. Evans, M. R. Weinstein, G. McGuinness, and for the Newborn Lung Project
Functional Assessment of a Multicenter Very Low-Birth-Weight Cohort at Age 5 Years
Arch Pediatr Adolesc Med, January 1, 2000; 154(1): 23 - 30.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. T. Singer, A. Salvator, S. Guo, M. Collin, L. Lilien, and J. Baley
Maternal Psychological Distress and Parenting Stress After the Birth of a Very Low-Birth-Weight Infant
JAMA, March 3, 1999; 281(9): 799 - 805.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. A. Banks, I. Seri, H. Ischiropoulos, J. Merrill, J. Rychik, and R. A. Ballard
Changes in Oxygenation With Inhaled Nitric Oxide in Severe Bronchopulmonary Dysplasia
Pediatrics, March 1, 1999; 103(3): 610 - 618.
[Abstract] [Full Text]


Home page
PediatricsHome page
R. Arendt, J. Angelopoulos, A. Salvator, and L. Singer
Motor Development of Cocaine-exposed Children at Age Two Years
Pediatrics, January 1, 1999; 103(1): 86 - 92.
[Abstract] [Full Text] [PDF]